These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36573194)

  • 1. High-sensitivity troponin I is associated with cardiovascular outcomes but not with breast arterial calcification among postmenopausal women.
    Iribarren C; Chandra M; Lee C; Sanchez G; Sam DL; Azamian FF; Cho HM; Ding H; Wong ND; Molloi S
    Int J Cardiol Cardiovasc Risk Prev; 2022 Dec; 15():200157. PubMed ID: 36573194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast Arterial Calcification: a Novel Cardiovascular Risk Enhancer Among Postmenopausal Women.
    Iribarren C; Chandra M; Lee C; Sanchez G; Sam DL; Azamian FF; Cho HM; Ding H; Wong ND; Molloi S
    Circ Cardiovasc Imaging; 2022 Mar; 15(3):e013526. PubMed ID: 35290077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-sensitivity Troponin I Predicts Major Cardiovascular Events after Non-Cardiac Surgery: A Vascular Events in Non-Cardiac Surgery Patients Cohort Evaluation (VISION) Substudy.
    Borges FK; Duceppe E; Heels-Ansdell D; Patel A; Sessler DI; Tandon V; Chan M; Pearse R; Srinathan S; Garg AX; Sapsford RJ; Ofori SN; Marcucci M; Kavsak PA; Pettit S; Spence J; Belley-Cote E; McGillion M; Whitlock R; Lamy A; Conen D; Thomas S; Mueller C; Jaffe AS; Devereaux PJ
    Clin Chem; 2023 Apr; 69(5):492-499. PubMed ID: 36762424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between High-Sensitivity Cardiac Troponin I and Cardiac Events in Elderly Women.
    Lewis JR; Lim WH; Wong G; Abbs S; Zhu K; Lim EM; Thompson PL; Prince RL
    J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28757482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-sensitivity cardiac troponin I and B-type natriuretic Peptide as predictors of vascular events in primary prevention: impact of statin therapy.
    Everett BM; Zeller T; Glynn RJ; Ridker PM; Blankenberg S
    Circulation; 2015 May; 131(21):1851-60. PubMed ID: 25825410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care).
    Cavender MA; White WB; Jarolim P; Bakris GL; Cushman WC; Kupfer S; Gao Q; Mehta CR; Zannad F; Cannon CP; Morrow DA
    Circulation; 2017 May; 135(20):1911-1921. PubMed ID: 28246236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines.
    Marston NA; Bonaca MP; Jarolim P; Goodrich EL; Bhatt DL; Steg PG; Cohen M; Storey RF; Johanson P; Wiviott SD; Braunwald E; Sabatine MS; Morrow DA
    JAMA Cardiol; 2020 Nov; 5(11):1255-1262. PubMed ID: 32756916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Troponin I and Incident Stroke in European Cohorts: Insights From the BiomarCaRE Project.
    Camen S; Palosaari T; Reinikainen J; Sprünker NA; Niiranen T; Gianfagna F; Vishram-Nielsen JKK; Costanzo S; Söderberg S; Palmieri L; Ferrario M; Peters A; Vartiainen E; Donati MB; Donfrancesco C; Borchini R; Börschel CS; Giampaoli S; Di Castelnuovo A; Magnussen C; Kee F; Koenig W; Blankenberg S; de Gaetano G; Tunstall-Pedoe H; Rospleszcz S; Jørgensen T; Zeller T; Kuulasmaa K; Linneberg A; Salomaa V; Iacoviello L; Schnabel RB;
    Stroke; 2020 Sep; 51(9):2770-2777. PubMed ID: 32811388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-Molecule Counting of High-Sensitivity Troponin I in Patients Referred for Diagnostic Angiography: Results From the CASABLANCA (Catheter Sampled Blood Archive in Cardiovascular Diseases) Study.
    McCarthy CP; Ibrahim NE; Lyass A; Li Y; Gaggin HK; Simon ML; Mukai R; Gandhi P; Kelly N; Motiwala SR; van Kimmenade RRJ; Massaro JM; D'Agostino RB; Januzzi JL
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29519811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between incidentally found breast arterial calcification on routine screening mammography and the development of coronary artery disease and stroke: results of a 10-year prospective study.
    Nudy M; Asmaro R; Jiang X; Schnatz PF
    Menopause; 2022 Dec; 29(12):1375-1380. PubMed ID: 36449932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated Breast Arterial Calcification Score Is Associated With Cardiovascular Outcomes and Mortality.
    Allen TS; Bui QM; Petersen GM; Mantey R; Wang J; Nerlekar N; Eghtedari M; Daniels LB
    JACC Adv; 2024 Nov; 3(11):101283. PubMed ID: 39399518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast vascular calcification and risk of coronary heart disease, stroke, and heart failure.
    Iribarren C; Go AS; Tolstykh I; Sidney S; Johnston SC; Spring DB
    J Womens Health (Larchmt); 2004 May; 13(4):381-9; discussion 390-2. PubMed ID: 15186654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of serial high-sensitivity troponin I measurements following acute cardiac decompensation-correlation with longer-term clinical outcomes and reverse remodelling.
    Wallenborn J; Marx A; Störk S; Güder G; Brenner S; Ertl G; Angermann CE
    Int J Cardiol; 2017 Apr; 232():199-207. PubMed ID: 28094131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Outlier Elimination on the 99th Percentile Upper Reference Limits of High-Sensitivity Cardiac Troponin I Assays Based on a Strictly Selected Healthy Reference Population.
    Ahn S; Kim HK; Lee W; Chun S; Min WK
    Ann Lab Med; 2022 May; 42(3):331-341. PubMed ID: 34907103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Sensitivity Troponin I and Coronary Computed Tomography in Symptomatic Outpatients With Suspected CAD: Insights From the PROMISE Trial.
    Januzzi JL; Suchindran S; Coles A; Ferencik M; Patel MR; Hoffmann U; Ginsburg GS; Douglas PS;
    JACC Cardiovasc Imaging; 2019 Jun; 12(6):1047-1055. PubMed ID: 29550314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction.
    Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM
    Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.
    Okuyama R; Ishii J; Takahashi H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Naruse H; Sarai M; Hasegawa M; Watanabe E; Suzuki A; Hayashi M; Izawa H; Yuzawa Y; Ozaki Y
    Heart Vessels; 2017 Jul; 32(7):880-892. PubMed ID: 28154958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Troponin elevations only detected with a high-sensitivity assay: clinical correlations and prognostic significance.
    Korley FK; Schulman SP; Sokoll LJ; DeFilippis AP; Stolbach AI; Bayram JD; Saheed MO; Omron R; Fernandez C; Lwin A; Cai SS; Post WS; Jaffe AS
    Acad Emerg Med; 2014 Jul; 21(7):727-35. PubMed ID: 25112512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and incident atrial fibrillation.
    Rienstra M; Yin X; Larson MG; Fontes JD; Magnani JW; McManus DD; McCabe EL; Coglianese EE; Amponsah M; Ho JE; Januzzi JL; Wollert KC; Fradley MG; Vasan RS; Ellinor PT; Wang TJ; Benjamin EJ
    Am Heart J; 2014 Jan; 167(1):109-115.e2. PubMed ID: 24332149
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.